BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26426967)

  • 1. Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain.
    Bural G; Torigian D; Basu S; Houseni M; Zhuge Y; Rubello D; Udupa J; Alavi A
    Nucl Med Commun; 2015 Dec; 36(12):1249-52. PubMed ID: 26426967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grey-Matter Metabolism in Relation with White-Matter Lesions in Older Hypertensive Patients with Subjective Memory Complaints: A Pilot Voxel-Based Analysis Study.
    Verger A; Hossu G; Kearney-Schwartz A; Bracard S; Roch V; Van der Gucht A; Fay R; Benetos A; Marie PY; Joly L
    Cerebrovasc Dis; 2016; 42(1-2):106-9. PubMed ID: 27071040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and performance of novel software to quantify metabolically active volumes and 3D partial volume corrected SUV and metabolic volumetric products of spinal bone marrow metastases on 18F-FDG-PET/CT.
    Torigian DA; Lopez RF; Alapati S; Bodapati G; Hofheinz F; van den Hoff J; Saboury B; Alavi A
    Hell J Nucl Med; 2011; 14(1):8-14. PubMed ID: 21512658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET.
    Tylski P; Stute S; Grotus N; Doyeux K; Hapdey S; Gardin I; Vanderlinden B; Buvat I
    J Nucl Med; 2010 Feb; 51(2):268-76. PubMed ID: 20080896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.
    Prieto E; Martí-Climent JM; Domínguez-Prado I; Garrastachu P; Díez-Valle R; Tejada S; Aristu JJ; Peñuelas I; Arbizu J
    J Nucl Med; 2011 Jun; 52(6):865-72. PubMed ID: 21571807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation.
    Gutierrez D; Montandon ML; Assal F; Allaoua M; Ratib O; Lövblad KO; Zaidi H
    Comput Med Imaging Graph; 2012 Dec; 36(8):610-9. PubMed ID: 23046730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM; Carandini T; Colombi A; Mercurio M; Ghezzi L; Giulietti G; Scarioni M; Arighi A; Fenoglio C; De Riz MA; Fumagalli GG; Basilico P; Serpente M; Bozzali M; Scarpini E; Galimberti D; Marotta G
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
    Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
    J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images.
    Hosokawa C; Ishii K; Kimura Y; Hyodo T; Hosono M; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Murakami T
    J Nucl Med; 2015 Dec; 56(12):1910-5. PubMed ID: 26359262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MRI and cannabinoid type 1 receptor PET templates constructed using DARTEL for spatial normalization of rat brains.
    Kronfeld A; Buchholz HG; Maus S; Reuss S; Müller-Forell W; Lutz B; Schreckenberger M; Miederer I
    Med Phys; 2015 Dec; 42(12):6875-84. PubMed ID: 26632044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging based bone marrow segmentation for quantitative calculation of pure red marrow metabolism using 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a novel application with significant implications for combined structure-function approach.
    Basu S; Houseni M; Bural G; Chamroonat W; Udupa J; Mishra S; Alavi A
    Mol Imaging Biol; 2007; 9(6):361-5. PubMed ID: 17899296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data.
    Kim JH; Lee JS; Song IC; Lee DS
    J Nucl Med; 2012 Dec; 53(12):1878-82. PubMed ID: 23081993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
    Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
    J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional variations of white and grey matter in older hypertensive patients with subjective memory complaints.
    Chetouani A; Chawki MB; Hossu G; Kearney-Schwartz A; Chauveau-Beuret F; Bracard S; Roch V; Lebon V; Marie PY; Benetos A; Joly L; Verger A
    Neuroimage Clin; 2018; 17():804-810. PubMed ID: 29276677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.
    Izquierdo-Garcia D; Davies JR; Graves MJ; Rudd JH; Gillard JH; Weissberg PL; Fryer TD; Warburton EA
    Stroke; 2009 Jan; 40(1):86-93. PubMed ID: 18927453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced grey matter metabolism due to white matter edema allows optimal assessment of brain tumors on 18F-FDG-PET.
    Pourdehnad M; Basu S; Duarte P; Okpaku AS; Saboury B; Hustinx R; Alavi A
    Hell J Nucl Med; 2011; 14(3):219-23. PubMed ID: 22087438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.